| Date Filed | Type | Description |
| 07/05/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 464 shares
@ $1.89, valued at
$877 |
|
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 857 shares
@ $2.23, valued at
$1.9k
|
|
| 03/13/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 18,192 shares
@ $0.84, valued at
$15.3k
|
|
| 11/09/2022 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 1,350,000 rights
@ $1.8, valued at
$2.4M
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |